HBK Investments’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-3,861
Closed -$355K – 815
2021
Q4
$355K Sell
3,861
-8,882
-70% -$1.06M ﹤0.01% 538
2021
Q3
$1.62M Sell
12,743
-17,272
-58% -$2.51M 0.01% 466
2021
Q2
$4.99M Buy
30,015
+12,109
+68% +$1.96M 0.02% 290
2021
Q1
$3.25M Buy
+17,906
New +$4.15M 0.01% 373

Other funds holding TDOC

HBK Investments's TDOC Position: Q1 2022 in Review

HBK Investments sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 3,861 shares — an estimated $355K sold.

HBK Investments first reported a position in TDOC in Q1 2021 and held it in 4 quarters. The position peaked at $4.99M in Q2 2021. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • HBK Investments reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • HBK Investments sold 3,861 Teladoc Health shares in Q1 2022, an estimated $355K.
  • HBK Investments first reported a position in Teladoc Health in Q1 2021 and held it in 4 quarters.
  • HBK Investments's Teladoc Health position peaked at $4.99M in Q2 2021.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on HBK Investments's 13F filing for Q1 2022, filed 16 May 2022.